CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Madrigal's Rezdiffra beats estimates; Gilead cuts jobs; Banyan debuts

EarningsRezdiffraPositive
AI Analysis

Summary

Madrigal Pharmaceuticals reported first quarter Rezdiffra sales of $311 million, exceeding analyst estimates by approximately $10 million. Gilead Sciences announced job cuts while Banyan made its market debut.

Financial Highlights

Revenue

$311 million

Importance:6/10
Sentiment:
0.70
earningssales_beatMASHRezdiffra
Related Companies

Read the original article

Published by Endpoints News on May 6, 2026 3:17 PM

Read Original